Serum markers alone can define high-risk smouldering multiple myeloma: new insights from the Czech Myeloma Group model

首页> 外文期刊>British Journal of Haematology >Serum markers alone can define high-risk smouldering multiple myeloma: new insights from the Czech Myeloma Group model

【24h】

Serum markers alone can define high-risk smouldering multiple myeloma: new insights from the Czech Myeloma Group model

机译：单独的血清标记可以定义高风险的闷烧多发性骨髓瘤：来自捷克骨髓瘤组模型的新见解

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《British Journal of Haematology》 |2020年第2期|共2页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词
serum markers; smoldering multiple myeloma; multiple myeloma;

机译：血清标记;闷烧多发性骨髓瘤;多发性骨髓瘤;

相似文献

外文文献
中文文献
专利

1. 形态学分类和临床变数对评估年老组和年轻组多发性骨髓瘤患者预后的意义 [J] . 洪登礼, 唐锦治中德临床肿瘤学杂志（英文版） . 2000,第004期
2. Serum markers alone can define high-risk smouldering multiple myeloma: new insights from the Czech Myeloma Group model [J] . British Journal of Haematology . 2020,第2期

机译：单独的血清标记可以定义高风险的闷烧多发性骨髓瘤：来自捷克骨髓瘤组模型的新见解
3. Lenalidomide plus dexamethasone versus observation in patients with high-risk smouldering multiple myeloma (QuiRedex): long-term follow-up of a randomised, controlled, phase 3 trial [J] . Mateos Maria-Victoria, Hernandez Miguel-Teodoro, Giraldo Pilar, The lancet oncology . 2016,第8期

机译：来那度胺联合地塞米松与高危阴燃性多发性骨髓瘤（QuiRedex）患者的观察：一项随机，对照，3期试验的长期随访
4. High-risk smoldering myeloma versus early detection of multiple myeloma: Current models, goals of therapy, and clinical implications [J] . Kunacheewa Chutima, Manasanch Elisabet E. Best practice & research: Clinical haematology . 2020,第1期

机译：高风险闷烧骨髓瘤与多发性骨髓瘤的早期检测：目前的模型，治疗目标，临床意义
5. Analysis of the secondary structure of blood serum proteins from patients with multiple myeloma [C] . M O Kobeleva, E A Telnaya, L V Plotnikova, International Conference PhysicA.SPb . 2020

机译：多发性骨髓瘤患者血清血清蛋白二次结构分析
6. A study of microRNAs associated with multiple myeloma pathogenesis and microRNAs/TP53 feedback circuit in human cancers, multiple myeloma and glioblastoma multiforme. [D] . Suh, Sung-Suk. 2012

机译：在人类癌症，多发性骨髓瘤和多形性胶质母细胞瘤中与多发性骨髓瘤发病机制相关的microRNA和microRNA / TP53反馈回路的研究。
7. Correspondence: High-risk myeloma: a gene expression–based risk-stratification model for newly diagnosed multiple myeloma treated with high-dose therapy is predictive of outcome in relapsed disease treated with single-agent bortezomib or high-dose dexamethasone [O] . Fenghuang Zhan, Bart Barlogie, George Mulligan, -1

机译：对应：高危骨髓瘤：采用高剂量治疗的新诊断多发性骨髓瘤的基于基因表达的风险分层模型可预测用单药硼替佐米或大剂量地塞米松治疗的复发性疾病的预后
8. A Validated Gene Expression Model of High-Risk Multiple Myeloma is Defined by Deregulated Expression of Genes Mapping to Chromosome 1 [O] . John D Shaughnessy, Fenghuang Zhan, Bart E Burington, 2006

机译：高风险的多发性骨髓瘤的基因表达模型的验证是通过映射到染色体1的基因的表达失控来定义的。

Serum markers alone can define high-risk smouldering multiple myeloma: new insights from the Czech Myeloma Group model

著录项

相似文献

相关主题

期刊订阅